article thumbnail

Moving towards oral delivery of biologics

European Pharmaceutical Review

Of the 175 new drugs approved by the US Food and Drug Administration (FDA) between 2016 and 2019, most were biologics. 8 Future potential Celltrion sees potential for the platform to be applicable to other biologics, according to SungHyun Kim, Head of the company’s Medical Science Division.

article thumbnail

What A Field Clinical Engineer In Neuromodulation Sales Does With Blake Williams

Evolve Your Success

FDA is happy with all of our results and our DMs are expressing that the physicians are happy with how everything is going. It’s hard to divvy all that because we work with medical affairs and medical science liaisons. By 2027, they are projected to be about $10 billion. All of our data collection is great.